Info

Amar J, Caranobe C, Sie P, Boneu B. Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit. Br J Haematol 76:94-100,1990.

Amiral J, Lormeau JC, Marfaing-Koka A, Vissac AM, Wolf M, Boyer-Neumann C, Tardy B, Herbert JM, Meyer D. Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 8:114-117,1997.

Arixtra Package Insert, Philadelphia, Pennsylvania. GlaxoSmithKline, 2006.

Arocas V, Bock SC, Raja S, Olson ST, Bjork I. Lysine 114 of antithrombin is of crucial importance for the affinity and kinetics of heparin pentasaccharide binding. J Biol Chem 276:43809-43817, 2001.

Bates SM, Weitz JI. The status of new anticoagulants. Br J Haematol 134:3-19, 2006.

Bauer KA. New anticoagulants. Hematology Am Soc Hematol Educ Program: 450-456,

0 0

Post a comment